Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Like I said 2034
Then the fda would have already said that in prior meetings but they haven’t. So your post is void
Sure bro sure
Sure does!
Because all those who know have shares and those who don’t have shares are unaware. If by chance there is sidelines money waiting then we will see a large spike in volume just after the meeting imo
BS. If that were the case every company would experience the same effect of customers not wanting to come back to them for business because every company has supply shortages.
To ensure correct context. The BIG IF is in reference to your opinion on saying an offering will be needed early.
That’s a BIG if
Again offering if even needed would be with a higher share price given the closeness of IDE submission. Therefore no need to offer what is not needed.
I’d like to think if it ever got to that point on needing more funding the share price would already be higher being that much closer to IDE submission if it hasn’t been submitted already. Therefore NOT A BIG HIGE DEAL. As they wouldn’t be offering 100’s of millions of shares
Not anymore
No 4’s at open ;)
Agreed
Little iHub and little stock twits is not enough. Not is Twitter, linked in, and Facebook. All need massive followings to move the needle when it comes to getting the word out but since the same individuals are followers we are essentially just letting all who know know again and again by the different platforms. We need substantial news, market pr, fda approval, significant pet revenue etc to make a solid move north in share price. I’m long and strong on this. It’s not an if for me but when.
Honestly I just think we are severely under the radar. That will change soon
Hidden gem, .25 coming quick. Not to far after is $1.40+
I wish I honestly knew how high the run up will go but I’m settled at 1.40 on the leveled side
$1.40+
You left out the buyers of the sellers you speak of
No buyers? How can they sell?
Nice
Nice. I’ll take a look
Seems like a legit company
So what’s going on with tHis one roofus
They only allow me to post once a day now so if it helps for me to repeat what I said then hopefully it’s clear.
“This thing is about done”
This thing is about done
Coming up on our monthly update. So they say. Doubt anything substantial if they even send an update
Betting that’s most
I honestly agree.
Big arm stretch!
Meeting set for early Fall hopefully per linked In response from RDGL
Thumbs up
“MK needs to focus on IDE application, up his communications game and get this puppy off ground. Only substantive position news can turn page. GLTA” that’s all that needs to be said.
Years with progression
This stock isn’t something that happens over night. If it were that easy cancer would have been cured decades ago. Buy in when you feel it’s a good entry point or don’t buy in a he choice is solely yours
Let’s just get the meeting scheduled, plan approved, tumor of appropriate size, and testing started. Hopefully all of that can be done before end of October.
My thought is that DPep was possibly thinking that initial run pop and not holding long term at that number.
True, I’d imagine these cost are fairly minor overall until something more substantial is introduced that requires major money.
Perhaps hard hitting PRs back to back to back (which has been their identity) 1st isopet expansion with multiple clinics possibly Canada , 2nd PR patent news, 3rd PR FDA meeting set and or FDA approved plan and can proceed with animal testing which (by this time) tumor is of appropriate size to start testing.
So a fear you have of not Having a PR on patent news is directly related to softening the blow of bad news in trying to raise additional money through dilution? Wouldn’t that imply we wouldn’t hear of patent news until end Q1 2023 since that’s when “end of runway” is?